|
US6387373B1
(en)
*
|
1993-01-15 |
2002-05-14 |
Novavax, Inc. |
Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
|
|
US6542183B1
(en)
|
1995-06-28 |
2003-04-01 |
Lynx Systems Developers, Inc. |
Event recording apparatus
|
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US6958148B1
(en)
*
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
KR100342835B1
(ko)
*
|
1998-07-31 |
2002-07-02 |
박호군 |
유전자 또는 약물을 효과적으로 전달하는 지방유제, 제형 및 이들의 제조방법
|
|
US6284234B1
(en)
*
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
|
EP1150918B1
(en)
|
1999-02-03 |
2004-09-15 |
Biosante Pharmaceuticals, Inc. |
Method of manufacturing therapeutic calcium phosphate particles
|
|
US20020054914A1
(en)
*
|
1999-02-03 |
2002-05-09 |
Tulin Morcol |
Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
|
|
US20040258763A1
(en)
*
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US8232320B2
(en)
|
1999-04-28 |
2012-07-31 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US7767216B2
(en)
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
|
US7655252B2
(en)
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
AU2001282064B2
(en)
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US6423707B1
(en)
|
2000-08-28 |
2002-07-23 |
California Pacific Medical Center |
Nitroimidazole ester analogues and therapeutic applications
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US6537591B2
(en)
|
2001-03-02 |
2003-03-25 |
Aquarium Pharmaceuticals, Inc. |
Aquatic animal treatment method and composition containing Pimenta extract
|
|
US20030185892A1
(en)
*
|
2001-08-17 |
2003-10-02 |
Bell Steve J. D. |
Intraocular delivery compositions and methods
|
|
NZ531492A
(en)
*
|
2001-08-28 |
2007-11-30 |
Eden Research Plc |
Treatment and prevention of fungal, bacterial, mycoplasma and phytoplasma infections in plants comprising terpene compounds in true solution
|
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
|
US6878693B2
(en)
*
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
|
US8663687B2
(en)
*
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
|
EP1455768A1
(en)
*
|
2001-12-07 |
2004-09-15 |
Eden Research Plc |
Respiratory infection prevention and treatment with terpene-containing compositions
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
EP1476194A4
(en)
*
|
2002-02-19 |
2005-05-18 |
Eden Research Plc |
COMPOSITIONS AND METHOD FOR PRESERVING FOODSTUFFS
|
|
EP1487504A4
(en)
*
|
2002-02-19 |
2010-09-01 |
Eden Research Plc |
IMPROVING THE QUALITY OF THE INTERIOR AIR AND ANTISEPTIC COMPOSITION INTENDED FOR THIS PURPOSE
|
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
WO2009012489A1
(en)
|
2007-07-19 |
2009-01-22 |
Novavax, Inc. |
Avian influenza chimeric vlps
|
|
JP5619337B2
(ja)
|
2003-10-10 |
2014-11-05 |
フェリング ビー．ブイ． |
皮膚残渣を最小限に抑えるための経皮的医薬製剤
|
|
US20050084513A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Board Of Regents |
Nanocoating for improving biocompatibility of medical implants
|
|
US20050084456A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Liping Tang |
Functionalized particles
|
|
HUE059183T2
(hu)
|
2004-01-23 |
2022-10-28 |
Eden Research Plc |
Eljárás fonalférgek irtására betokozott terpén komponens alkalmazásával
|
|
WO2005084637A2
(en)
*
|
2004-02-13 |
2005-09-15 |
Nod Pharmaceuticals, Inc. |
Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
|
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
DK1753529T3
(da)
|
2004-05-20 |
2013-11-11 |
Eden Research Plc |
Komposition indeholdende en hul glucan-partikel eller en hul cellevægspartikel, der indkapsler en terpenkomponent, fremgangsmåder til fremstilling og anvendelse af disse
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
WO2006036982A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Drug delivery coating for use with a stent
|
|
WO2006036969A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Formation of barrier layer
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
CA2586035A1
(en)
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
WO2006113668A1
(en)
*
|
2005-04-15 |
2006-10-26 |
University Of South Florida |
A method of transdermal drug delivery using hyaluronic acid nanoparticles
|
|
US8067399B2
(en)
*
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
|
CA2618655C
(en)
|
2005-07-18 |
2015-12-22 |
University Of Massachusetts Lowell |
Compositions and methods for making and using nanoemulsions
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
RS52671B
(en)
|
2005-10-12 |
2013-06-28 |
Unimed Pharmaceuticals Llc |
IMPROVED TESTOSTERON GEL AND USE PROCEDURE
|
|
SG2014012868A
(en)
|
2005-10-18 |
2014-09-26 |
Novavax Inc |
Functional influenza virus like particles (vlps)
|
|
JP6027718B2
(ja)
|
2005-11-30 |
2016-11-16 |
エーデン リサーチ ピーエルシー |
チモール、オイゲノール、ゲラニオール、シトラール、及びｌ−カルボンから選択されたテルペン又はテルペン混合物を含む組成物及び方法
|
|
ES2848707T3
(es)
|
2005-11-30 |
2021-08-11 |
Eden Research Plc |
Cápsulas insecticidas que contienen timol y métodos de fabricación y uso de las mismas
|
|
DK3144013T3
(en)
|
2005-12-01 |
2019-03-04 |
Univ Massachusetts Lowell |
Botulinum nanoemulsions
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
US10137083B2
(en)
*
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
|
EP2001439A2
(en)
*
|
2006-03-07 |
2008-12-17 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
|
EP2010149A1
(en)
*
|
2006-04-07 |
2009-01-07 |
Novavax, Inc. |
Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
|
|
CN101426475A
(zh)
*
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
|
US9040250B2
(en)
*
|
2006-09-07 |
2015-05-26 |
The United States Of America, As Represented By The Secretary Of The Navy |
Binding interaction of proanthocyanidins with bacteria and bacterial components
|
|
WO2008039864A1
(en)
*
|
2006-09-26 |
2008-04-03 |
Novavax, Inc. |
Emulsion formulations for transdermal delivery of poorly water soluble active agents
|
|
WO2008057328A2
(en)
|
2006-11-06 |
2008-05-15 |
Atrium Medical Corporation |
Tissue separating device with reinforced support for anchoring mechanisms
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
BRPI0719732A2
(pt)
|
2006-12-01 |
2017-05-16 |
Anterios Inc |
nanopartículas de peptídeo e usos para as mesmas
|
|
BRPI0719756A2
(pt)
*
|
2006-12-01 |
2014-01-21 |
Anterios Inc |
Nanopartículas de entidades anfifílicas
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
US20080207756A1
(en)
*
|
2007-02-27 |
2008-08-28 |
Atrium Medical Corporation |
Bio-absorbable oil suspension
|
|
US8747872B2
(en)
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
KR20100050443A
(ko)
|
2007-05-31 |
2010-05-13 |
안테리오스, 인코퍼레이티드 |
핵산 나노입자 및 이의 용도
|
|
CN105147608B
(zh)
*
|
2008-06-26 |
2019-12-10 |
安特里奥公司 |
真皮递送
|
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
|
DK3067064T3
(da)
|
2008-12-09 |
2020-06-08 |
Novavax Inc |
Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
MX2011010547A
(es)
|
2009-04-08 |
2011-12-16 |
Cadila Healthcare Ltd |
Composiciones farmaceuticas estables de diclofenaco.
|
|
US8470304B2
(en)
|
2009-08-04 |
2013-06-25 |
Avidas Pharmaceuticals Llc |
Therapeutic vitamin D sun-protecting formulations and methods for their use
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
US20110045050A1
(en)
*
|
2009-08-24 |
2011-02-24 |
Atrium Medical Corporation |
Nanoemulsion formulations for direct delivery
|
|
WO2012009707A2
(en)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
WO2012053012A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions comprising tfflocolchicoside
|
|
US9789123B2
(en)
|
2010-10-21 |
2017-10-17 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
|
|
US20130295145A1
(en)
|
2010-10-21 |
2013-11-07 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions comprising etodolac
|
|
US9629785B2
(en)
|
2010-10-21 |
2017-04-25 |
Cadila Healthcare Limited |
Pharmaceutical compositions comprising nano size droplets of skin whitening agents
|
|
WO2012053013A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Pharmaceutical compositions of anti-acne agents
|
|
WO2012053007A1
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
|
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
|
WO2012059936A1
(en)
|
2010-11-03 |
2012-05-10 |
Padma Venkitachalam Devarajan |
Pharmaceutical compositions for colloidal drug delivery
|
|
SI2635257T1
(en)
|
2010-11-05 |
2018-01-31 |
Novavax, Inc. |
Particles as rabies virus glycoproteins
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
CA2818691C
(en)
|
2010-12-21 |
2021-08-03 |
Science Applications International Corporation |
Methods to identify actin or rdg peptide motifs in wound sites and compositions and methods for wound treatment
|
|
US20120189677A1
(en)
*
|
2011-01-20 |
2012-07-26 |
Stephen Tonge |
Formulations
|
|
WO2012127496A1
(en)
|
2011-03-01 |
2012-09-27 |
Cadila Healthcare Limited |
Stable pharmaceutical compositions of lornoxicam or salts thereof
|
|
EP2726071B1
(en)
|
2011-06-29 |
2023-10-11 |
Avidas Pharmaceuticals LLC |
Topical formulations including lipid microcapsule delivery vehicles and their uses
|
|
WO2013014680A1
(en)
|
2011-07-28 |
2013-01-31 |
Cadila Healthcare Limited |
Method for treatment of pain and inflammation
|
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10322089B2
(en)
*
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
GB201220940D0
(en)
|
2012-11-21 |
2013-01-02 |
Eden Research Plc |
Method P
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
KR102399854B1
(ko)
|
2013-09-19 |
2022-05-19 |
노바백스, 인코포레이티드 |
면역원성 중동호흡기증후군 코로나바이러스 (ΜＥＲＳ-ＣｏＶ) 조성물 및 방법
|
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
KR20170054429A
(ko)
|
2014-09-03 |
2017-05-17 |
제네세규스 인코포레이티드 |
치료용 나노입자 및 관련 조성물, 방법, 및 시스템
|
|
WO2016094316A1
(en)
*
|
2014-12-08 |
2016-06-16 |
Synaptamine, Inc. |
Anti-rds compounds and method of manufacture and administration thereof to induce dopamine homeostatis
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
AU2016315478B2
(en)
|
2015-09-03 |
2023-07-13 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
|
CA3020153A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
CA3022840A1
(en)
|
2016-05-05 |
2017-11-09 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
|
US11311496B2
(en)
|
2016-11-21 |
2022-04-26 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
|
US20180147215A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
WO2019023196A1
(en)
|
2017-07-24 |
2019-01-31 |
Novavax, Inc. |
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
|
|
CN110881462A
(zh)
*
|
2019-11-25 |
2020-03-17 |
南京启佑生物科技有限公司 |
一种基于磷酸盐与金属离子的纳米农药复合制剂及其制备方法
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|